CDSCO Panel Rejects Dr Reddy’s Proposal to Study FDC of Ketorolac plus Serratiopeptidase Capsules
New Delhi: Citing there is no rationality of the combination and significant benefits, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has rejected the drug major Dr. Reddys Laboratories’ proposal to conduct a clinical trial of fixed-dose combination (FDC) Ketorolac Tromethamine 10mg plus Serratiopeptidase 15mg Capsules. This came after […]